Scarica l'app Stockscreener
12.79
2.65%
0.33
Day One Biopharmaceuticals Inc Azioni (DAWN) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
12.18%
66.77
|
59.52 | 51.44 | 49.25 | 45.85 |
| Operating Income/Loss |
12.18%
-66.77
|
-59.52 | -51.44 | -49.25 | -45.85 |
| Income/Loss From Continuing Operations Before Tax |
14.49%
-62.41
|
-54.51 | -46.15 | -45.86 | -42.39 |
| Income/Loss From Continuing Operations After Tax |
14.49%
-62.41
|
-54.51 | -46.15 | -45.86 | -42.39 |
|
Net Income/Loss
|
14.49%
-62.41
|
-54.51 | -46.15 | -45.86 | -42.39 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
4,046%
86.68
|
2.0908 | 85.95 | 74.96 | 71.97 |
| Diluted Average Shares |
4,046%
86.68
|
2.0908 | 85.95 | 74.96 | 71.97 |
| Basic Earnings Per Share |
12.50%
-0.72
|
-0.64 | -0.54 | -0.61 | -0.59 |
| Diluted Earnings Per Share |
12.50%
-0.72
|
-0.64 | -0.54 | -0.61 | -0.59 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):